Carisma Therapeutics is pioneering the development of CAR macrophages, a disruptive approach to immunotherapy.
Philadelphia, PA
Joined November 2020
- Tweets154
- Following15
- Followers505
- Likes25
Pinned Tweet
The Carisma mission has always been centered around patients. As we strive to deliver for them, we are expanding the promise of immunotherapy. RSVP to our upcoming webcast to learn about our CAR-Macrophage platform and the latest clinical trial data: bit.ly/39dHRwm
Don’t miss $CARM President & CEO Steve Kelly’s fireside chat today at 7th Annual Evercore HealthCONx Conference at 9:35 am ET. The webcast is available on the investor section of our website: bit.ly/3TvbKNh
Happy Thanksgiving from Carisma Therapeutics!
May your day be filled with warmth, happiness, and cherished moments with loved ones. Wishing you and your families a joyous and memorable Thanksgiving!
Today we announced that President and CEO Steve Kelly will participate in a fireside chat at the 7th Annual Evercore HealthCONx Conference on December 5 at 9:35 am ET.
For full details and webcast information, read our press release: ir.carismatx.com/news-releas…
Today at AASLD meeting, we’re excited to share new preclinical data showcasing the potential of our engineered macrophages to transform the treatment of liver fibrosis.
This #VeteransDay, we honor the brave men and women who have selflessly served in our armed forces. We are deeply grateful for your sacrifice and dedication to protecting our freedom. Thank you for your service.
#VeteransDay2024 #ThankYouVeterans #CarismaHonors
Exciting news! Today, we shared promising preclinical data on our anti-GPC3 in vivo CAR-M therapy for hepatocellular carcinoma (#HCC). This off-the-shelf approach—developed with @Moderna_tx—shows strong potential in targeting GPC3+ tumors.
Learn more: ir.carismatx.com/news-releas…
Today, we shared our business update and financial results for the third quarter of 2024. For a full overview of our progress and financials, read the press release here: ir.carismatx.com/news-releas…
#biotech #financialresults #Q32024 #CarismaTherapeutics #innovation
We’re excited to be part of #SITC2024 in Houston! On November 8, 2024, we will showcase our trial-in-progress poster for the Phase 1 study of anti-HER2 CAR-Monocytes targeting solid tumors.
#CellTherapy #immunotherapy #Oncology
We're excited to participate in #SITC2024 in Houston! Join us on November 8, 2024, as we, alongside Moderna, present new preclinical efficacy data on our anti-GPC3 in vivo CAR-M therapy for hepatocellular carcinoma. Link: ir.carismatx.com/news-releas…
#CellTherapy #immunotherapy
Excited to welcome Sohanya Cheng to Carisma’s Board of Directors! Ms. Cheng’s expertise in oncology will be invaluable as we continue to advance our pipeline. Grateful to Michael Torok for his valuable contributions and wishing him the best.
More details: ir.carismatx.com/news-releas…
We're excited to present at #SITC2024! Join us on Nov 8, as we, alongside @moderna_tx , share promising data on anti-GPC3 in vivo CAR-M therapy for HCC. We'll also present TIP poster for the Ph1 study of anti-HER2 CAR-Monocytes targeting solid tumors. ir.carismatx.com/news-releas…
Tune in today at 4:00 pm ET for $CARM President & CEO Steve Kelly’s presentation at the Chardan 8th Annual Genetic Medicines Conference. A link to the webcast is available on the investor section of our website: bit.ly/3TvbKNh
Don’t miss $CARM President & CEO Steve Kelly’s presentation today at the H.C. Wainwright Healthcare Conference at 1:30 pm ET. The webcast is available on the investor section of our website: bit.ly/3TvbKNh
Tune in today at 12:50 pm ET, $CARM CEO Steve Kelly will present at the Baird Global Healthcare Conference.: bit.ly/3TvbKNh
Today, we announced the expansion of our collaboration with @Moderna to develop two in vivo CAR-M therapies for autoimmune diseases. This builds on our preclinical success in oncology, advancing potential new treatments for patients. Link: ir.carismatx.com/news-releas…
This week, we will be presenting at the upcoming Baird Global Healthcare Conference and H.C. Wainwright Healthcare Conference. Read our press release for full details: ir.carismatx.com/news-releas…
Today we provided a business update and reported financial results for the second quarter 2024. For full details and results, read today’s press release: ir.carismatx.com/news-releas…
Tune in today at 10:55 am ET for Carisma Therapeutics Chief Scientific Officer Michael Klichinsky’s presentation at the Immuno-Oncology Summit 2024 in Philadelphia. Event details: 12th Annual Immuno-Oncology Summit | August 7-9, 2024 | Philadelphia, PA
We are excited to announce the addition of two distinguished leaders, Dr. Scott Friedman and Dr. Ira Tabas, to Carisma’s Scientific Advisory Board!
Read more in the press release here: ir.carismatx.com/news-releas…
We are excited to announce new additions to Carisma's Board! Marella Thorell and David Scadden, M.D. bring vast experience from the life science sector that will be instrumental in advancing our cell therapy platform focused on engineered macrophages. ir.carismatx.com/news-releas…